Bird flu fears send drug sales soaring

The maker of a key bird flu drug said today that sales of the treatment had more than doubled as countries stocked up ahead of a possible pandemic.

Swiss firm Roche said sales of Tamiflu, which is seen as the best treatment for bird flu, soared to 279 million Swiss francs (€179m) in its third quarter.